Chapter 22 - Anna Carter’s Patent
Anna Carter was thirty-four when she co-developed the original diagnostic method.
Not at Carter Biomedical.
At a university lab.
Henry later funded commercialization.
Arthur negotiated patent pooling.
Three researchers assigned rights.
Anna retained a contingent share.
Then family conflict erupted.
She left.
Her contribution faded from company histories.
Not removed from patent documents.
Just rarely mentioned.
The $31.6 million sale represented accumulated rights at one moment.
But the platform later generated far more.
Over $400 million in downstream licensing revenue.
Evan stared.
“So we’re reopening all of that?”
“No,” independent counsel said.
“Not necessarily.”
Most later transactions were legally valid.
The disputed issue was the twelve-year-old transfer of Anna’s voting authority.
That transfer enabled one sale.
If Anna had been asked while alive, would she have approved?
No one could know.
But they found one clue.
A letter from Anna to Arthur three years before the sale.
Arthur had asked whether she wanted to rejoin the patent pool.
Anna replied:
I want my name attached to my work.
I do not want Carter family money.
If the technology is licensed, direct my economic share toward patient access.
Everyone went silent.
Not inheritance.
Purpose.
Anna wanted value used to help patients afford diagnostics.
Arthur never implemented it.
Why?
Because he thought the letter lacked formal legal instructions.
Henry later found it and froze Halcyon while seeking Anna’s heirs.
Again, legal caution prevented moral action.
Evan read the line repeatedly.
“She already told them.”
“Yes.”
“So why are we debating what she wanted?”
Because law.
Because heirs.
Because institutional obligations.
Because dead people’s letters do not automatically rewrite trusts.
Evan’s independent attorney proposed a structure.
Court-supervised settlement.
Recognize Anna’s authorship publicly.
Allocate disputed proceeds proportionally to legitimate patent contributors.
Evan, as possible descendant beneficiary, could waive personal claim in favor of an access foundation if he chose.
No one could force him.
Daniel said nothing.
Important.
Evan had spent much of his life reacting against Graham.
Daniel would not replace one controlling father with another adult telling him what the “good” choice was.
Evan took a week.
Then asked Claire Holloway to meet.
“Did you know Anna?”
“Once.”
“What was she like?”
“Angry.”
Evan smiled.
“At what?”
“Almost everything.”
“Good.”
Claire Holloway remembered Anna hated family myth.
She did not consider herself exiled victim.
She had made choices too.
Refused some reconciliation attempts.
Said cruel things.
Rejected Henry even when he apologized.
Complex.
Real.
Then Evan asked:
“Would she want me to keep anything?”
Claire refused to answer for a dead woman.
“I can tell you what she wrote.”
That was all.
Evan chose to waive most personal economic claim.
Not all.
That surprised Daniel.
Evan kept a modest portion assigned to Anna’s family share.
$1.2 million after settlement.
Why?
“My mother rejected money because she wanted nothing from the Carters.”
He looked at Daniel.
“I don't want my choice to be controlled by her refusal either.”
Fair.
He placed half into his own education and housing trust.
The other half into legal-aid funding for coercion and financial-abuse cases.
The remaining disputed Anna proceeds seeded:
ANNA CARTER DIAGNOSTIC ACCESS FUND.
No Carter family control.
No Voss control.
Independent board.
Patient representatives.
Inventor credit corrected.
Halcyon’s $31.6 million was finally allocated through court order.
Not magically given to one heir.
The account closed.
Almost.
One residual item remained.
HC-1 authority.
Claire Holloway was still technically first custodian.
HC-2:
Claire Carter.
The governing document required both custodians to sign final dissolution.
Claire Holloway hesitated.
“Before I sign, Daniel needs to know why Henry selected his wife.”
Claire Carter looked at her.
“I assumed because I investigated him.”
“No.”
“Then why?”
Claire Holloway took out an old photograph.
Seven years earlier.
Henry Carter at a hospital fundraiser.
Claire Carter in the background.
They had not formally met yet.
Henry was looking at her.
On the back:
SHE DID WHAT DANIEL COULD NOT DO AT TWENTY.
Daniel frowned.
“What?”
Claire Holloway answered:
“She reported her own employer.”
Before meeting Daniel, Claire Carter had uncovered insurance billing irregularities at the hospital where she worked.
She reported them despite pressure.
Lost promotion.
Changed jobs.
Henry learned about it through a board contact.
When Daniel later introduced Claire as his girlfriend, Henry recognized her name.
He did not approve of their relationship because of lineage or scheme.
He trusted her courage.
More than Daniel’s.
Daniel felt the sting.
Deservedly.
Henry engraved HC-2 into the bracelet because he believed that if Halcyon ever reopened, Claire would do what Daniel had failed to do at twenty.
Tell the truth.
Claire looked furious.
“He used my ethics without my consent.”
Claire Holloway nodded.
“Yes.”
“Even as a compliment, that's control.”
“Yes.”
Daniel almost smiled.
Both Claires agreed immediately.
Then Claire Carter removed her bracelet.
“I'll sign the dissolution.”
“But?”
“But after that, HC-2 dies with Halcyon.”
No successor.
No secret custodian.
No child inherits the bracelet’s duty.
Noah and Lily would not receive hidden codes.
The chain ended.
Then Claire Holloway said:
“One problem.”
Daniel sighed.
“What?”
“Halcyon cannot dissolve until Case Nine’s death record is corrected.”
“Anna is actually dead.”
“Yes.”
“So what record?”
Claire placed one final document down.
The original false-death status had never been removed from one external trust.
Anna Carter currently existed in that archive as dying twice.
One false date.
One real date.
May you like
And because the false date remained active—
a foundation created in her name had been controlled for twelve years by the wrong successor.
